Electrophysiology & Arrhythmia

Omron Healthcare launched its latest innovation, Complete, May 1, marking the first time a blood pressure (BP) monitor with electrocardiogram (ECG) capabilities has hit the commercial market.

The FDA on May 1 announced it cleared Medtronic’s Attain Stability Quad MRI SureScan left heart lead for commercial use in the U.S.

The Heart Rhythm Society's 2019 scientific sessions will be held May 8-11 in San Francisco, a venue that enabled the program committee to tap into Silicon Valley’s expertise with digital health, emerging technology and innovation. HRS.19 Program Director Christine Albert, MD, MPH, gave Cardiovascular Business a preview of meeting highlights.

A deep learning model trained on more than 1.5 million electrocardiograms can reliably detect hyperkalemia—or abnormally high potassium levels in the blood—among patients with chronic kidney disease (CKD), Mayo Clinic researchers reported April 3 in JAMA Cardiology.

Left atrial appendage (LAA) closure with the Watchman device was associated with low rates of stroke and bleeding events in high-risk atrial fibrillation patients over a two-year follow-up period, according to a real-world analysis published April 3 in Circulation: Electrophysiology and Arrhythmia.

An animal study published in Experimental Neurology suggests recovery from cardiac arrest is inhibited by exposure to white light—the same kind that normally illuminates hospital rooms.

Compared to warfarin, all direct oral anticoagulants (DOACs) were associated with fewer cardiovascular events including heart attacks and strokes in a study of Medicare patients with both nonvalvular atrial fibrillation and heart failure. But apixaban appeared to offer the best balance of protecting against these events while minimizing bleeding risk.

The proportion of out-of-hospital cardiac arrest (OHCA) patients in Sweden who received bystander CPR increased by 27.4 percent over an 18-year period, according to a new study, with much of that growth attributed to the increased utilization of chest compression-only CPR.

A new AI software can quickly and accurately determine the manufacturer and model of a cardiac rhythm device from an x-ray, possibly speeding up treatment when the devices fail.

A mesh envelope embedded with antibiotics cut the risk of major device-related infections by 40 percent when placed around cardiac implantable electronic devices (CIEDs) like pacemakers and defibrillators, researchers reported in the New England Journal of Medicine.

A catheter ablation protocol for atrial fibrillation (AFib) including only “the bare essentials” of the procedure delivered similar outcomes as a more involved strategy featuring pulmonary vein mapping, according to research presented at EHRA 2019.

A remote monitoring protocol for heart failure patients with implantable electronic devices helped more of them stay out of the hospital over a one-year period than standard in-person visits, researchers reported at EHRA 2019.